Default: Prostaglandins and Other Lipid Mediators

ISSN: 1098-8823

Journal Home

Journal Guideline

Prostaglandins and Other Lipid Mediators Q2 Unclaimed

Elsevier Inc. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Prostaglandins and Other Lipid Mediators is a journal indexed in SJR in Cell Biology and Physiology with an H index of 86. It has an SJR impact factor of 0,671 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,671.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Prostaglandins and Other Lipid Mediators

0,671

SJR Impact factor

86

H Index

56

Total Docs (Last Year)

156

Total Docs (3 years)

3893

Total Refs

431

Total Cites (3 years)

151

Citable Docs (3 years)

2.43

Cites/Doc (2 years)

69.52

Ref/Doc

Comments

No comments ... Be the first to comment!

Other journals with similar parameters


Cellular Signalling Q2
Cilia Q2
Mitochondrion Q2
Journal of Cellular and Molecular Medicine Q2
Aging Q2

Compare this journals

Aims and Scope





Best articles by citations

Manganese-Lipoxygenase: A novel model of lipoxygenation

View more

Human Astrocytoma Cells Express Two Thromboxane A2 Receptor Subtypes that Communicate with Gq and G12

View more

Role of platelet-activating factor in acid-induced lung injury

View more

Eicosanoids and isoeicosanoids and the cardiovascular system

View more

Urinary thromboxane A2/prostacyclin balance reflects the pathological state of a diabetic

View more

Leukotriene B4 evokes the pre-nuclear envelope breakdown calcium signal

View more

Putative metabolites of anandamide: Activities and occurrence

View more

Vascular endothelium: An integrator of biomechanical stimuli in the cardiovascular system

View more

Signaling to release lysosomal enzyme by leukotriene B4 and platelet activating factor

View more

Acetyl-11-keto-beta-boswellic acid (AKBA) is cytotoxic for meningioma cells and inhibits phosphorylation of the extracellular-signal regulated kinase 1 and 2

View more

Investigation into the involvement of phospholipases A2 and MAP kinases in modulation of AA release and cell growth in A549 cells

View more

The constriction of the human pulmonary artery by LTC4 is mediated via a CYSLT2 receptor and counteracted by prostacyclin release

View more
SHOW MORE ARTICLES

Role of cytosolic phospholipase A2 in vivo and in vitro

View more

Studies on 3-hydroxy-oxylipins, a group of novel eicosanoids produced by fungi

View more

Aqueous flare elevation induced by transcorneal application of highly selective agonists for prostaglandin E2 receptor subtypes in pigmented rabbits: Effect of tetramethylpyrazine

View more

PLIP, a novel cPLA2-interacting protein, increasesapoptosis induced by serum deprivation and by TNFa, enhances TNFa-induced COX-2 expression and has in vitro histon acetylase transferase (HAT) activity

View more

Inhibition of translation initiation mediates the anticancer effect of eicosapentaenoic acid

View more

EX-FABP,extracellular fatty acid binding protein, is modulated in culture by inflammatory-antiinflammatory agents and is expressed in vivo during chicken embryo development and in inflammation

View more

Different actions of noradrenaline and nitric oxide on the output of prostaglandins and progesterone in cultured bovine luteal cells

View more

Snapshot of the cyclooxygenase reaction pathway: Structure of prostaglandin at the active site of COX-2

View more

The development of COX-1/COX-2 double knockouts

View more

Transcriptional regulation of prostaglandin-H-synthase-1 in the amnion-derived AV3 cell line

View more

Physical interaction with B4 integrin regulates arachidonate 12-lipoxygenase activity

View more

cDNA cloning and mutagenesis study of liver-type progstaglandin F synthase, and identification of the prostaglandin F producing cells in the liver

View more

FAQS